These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7396563)

  • 1. The experimental chemotherapy of leishmaniasis, V. The activity of potential leishmanicides against 'L. infantum LV9' in NMRI mice.
    Peters W; Trotter ER; Robinson BL
    Ann Trop Med Parasitol; 1980 Jun; 74(3):289-97. PubMed ID: 7396563
    [No Abstract]   [Full Text] [Related]  

  • 2. The experimental chemotherapy of leishmaniasis, VI. The development of rodent models for cutaneous infection with L. major and L. mexicana amazonensis.
    Trotter ER; Peters W; Robinson BL
    Ann Trop Med Parasitol; 1980 Jun; 74(3):299-319. PubMed ID: 7396564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The experimental chemotherapy of leishmaniasis, IV. The development of a rodent model for visceral infection.
    Trotter ER; Peters W; Robinson BL
    Ann Trop Med Parasitol; 1980 Apr; 74(2):127-38. PubMed ID: 6254453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of IFN-gamma in experimental Leishmania infantum murine visceral leishmaniasis.
    Garin YJ; Sulahian A; Gangneux JP; Derouin F
    Pathol Biol (Paris); 1997 Jan; 45(1):48-51. PubMed ID: 9097846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
    J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Desmodium gangeticum extract and its fractions against experimental visceral leishmaniasis.
    Singh N; Mishra PK; Kapil A; Arya KR; Maurya R; Dube A
    J Ethnopharmacol; 2005 Apr; 98(1-2):83-8. PubMed ID: 15763367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of new diamidines against Leishmania donovani infection.
    Chauhan PM; Iyer RN; Shankhdhar V; Guru PY; Sen AB
    Indian J Exp Biol; 1993 Feb; 31(2):196-8. PubMed ID: 8500833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections in immunocompetent and immune-deficient mice with promastigotes of a North American isolate of Leishmania infantum.
    Rosypal AC; Zajac AM; Troy GC; Lindsay DS
    Vet Parasitol; 2005 Jun; 130(1-2):19-27. PubMed ID: 15893066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of integral membrane proteins of Leishmania promastigotes and evaluation of their prophylactic potential in hamsters against experimental visceral leishmaniasis.
    Garg R; Srivastava JK; Pal A; Naik S; Dube A
    Vaccine; 2005 Jan; 23(9):1189-96. PubMed ID: 15629362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes in leishmaniasis: therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline.
    Alving CR; Steck EA; Chapman WL; Waits VB; Hendricks LD; Swartz GM; Hanson WL
    Life Sci; 1980 Jun; 26(26):2231-8. PubMed ID: 7401920
    [No Abstract]   [Full Text] [Related]  

  • 13. [Search for a vaccine against leishmaniasis].
    Poot J
    Tijdschr Diergeneeskd; 2006 Oct; 131(19):694-5. PubMed ID: 17052076
    [No Abstract]   [Full Text] [Related]  

  • 14. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
    Oliva G; Foglia Manzillo V; Pagano A
    Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmaniasis: military significance and new hope for treatment.
    Kinnamon KE; Steck EA; Loizeaux PS; Hendricks LD; Waits VB; Chapman WL; Hanson WL
    Mil Med; 1979 Oct; 144(10):660-4. PubMed ID: 119170
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo anti-leishmanial activity of triterpenoid saponins isolated from Maesa balansae and some chemical derivatives.
    Germonprez N; Maes L; Van Puyvelde L; Van Tri M; Tuan DA; De Kimpe N
    J Med Chem; 2005 Jan; 48(1):32-7. PubMed ID: 15633999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization of Leishmania dovovani parasite inoculum dose and route of challenge for use in infectivity studies: is it necessary?
    Mbati PA
    East Afr Med J; 1995 Dec; 72(12):804. PubMed ID: 8689982
    [No Abstract]   [Full Text] [Related]  

  • 18. Kala-azar: current status of experimental chemotherapy.
    Katiyar JC; Anuradha ; Sharma S
    Med Res Rev; 1992 Sep; 12(5):473-504. PubMed ID: 1513185
    [No Abstract]   [Full Text] [Related]  

  • 19. The experimental chemotherapy of leishmaniasis, VII. Drug responses of L. major and L. mexicana amazonensis, with an analysis of promising chemical leads to new antileishmanial agents.
    Peters W; Trotter ER; Robinson BL
    Ann Trop Med Parasitol; 1980 Jun; 74(3):321-35. PubMed ID: 7396565
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
    Everlien H; Hockertz S
    Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.